An analyst at Piper Jaffray has just downgraded shares of Clinical Data (NASDAQ: CLDA) from Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE